Understanding the asthmatic response to an experimental rhinovirus infection: Exploring the effects of blocking IgE
Peter W. Heymann(University of Virginia), Ronald B. Turner(University of Virginia), Matthew McGraw(University of Rochester Medicine), Larry Borish(University of Virginia Health System), Lisa M. Wheatley(Johns Hopkins University), Judith A. Woodfolk(University of Virginia), Mark R. Conaway(Duke Medical Center), Joshua L. Kennedy(Arkansas Children's Hospital), Thomas A.E. Platts‐Mills(University of Virginia), John W. Steinke(Baylor College of Medicine), W. Gerald Teague(University of Virginia), Amy Adams(University of Louisville), Deborah D. Murphy(University of Virginia), Anne‐Marie Irani(Brigham and Women's Hospital), Lyndsey M. Muehling(University of Virginia), Stephen V. Early(University of Virginia), Holliday T. Carper(University of Virginia)
Cited by 47
Related Papers
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
|European Respiratory Journal|2013|3.9k
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
|New England Journal of Medicine|2008|1.5k
Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program
|Journal of Allergy and Clinical Immunology|2007|933
Hydrocortisone With or Without Mitoxantrone in Men With Hormone-Refractory Prostate Cancer: Results of the Cancer and Leukemia Group B 9182 Study
|Journal of Clinical Oncology|1999|893
The relevance of tick bites to the production of IgE antibodies to the mammalian oligosaccharide galactose-α-1,3-galactose
|Journal of Allergy and Clinical Immunology|2011|646